Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 18,209 | 22,776 | 18,123 | 21,560 | 19,022 |
| Operating Income | -18,209 | -22,776 | -18,123 | -21,560 | -19,022 |
| Other Income | -9 | 62 | 90 | 142 | 294 |
| Pre-tax Income | -18,218 | -22,714 | -18,033 | -21,418 | -18,728 |
| Net Income Continuous | -18,218 | -22,714 | -18,033 | -21,418 | -18,728 |
| Net Income | $-18,218 | $-22,714 | $-18,033 | $-21,418 | $-18,728 |
| EPS Basic Total Ops | -7.00 | -6.50 | -7.25 | -10.00 | -14.25 |
| EPS Basic Continuous Ops | -6.94 | -6.39 | -7.24 | -10.11 | -14.15 |
| EPS Diluted Total Ops | -7.00 | -6.50 | -7.25 | -10.00 | -14.25 |
| EPS Diluted Continuous Ops | -6.94 | -6.39 | -7.24 | -10.11 | -14.15 |
| EBITDA(a) | $-17,673 | $-22,287 | $-17,861 | $-21,348 | $-18,916 |